{"filing":{"accession_number":"0000318154-26-000097","cik":"0000318154","ticker":null,"company_name":"AMGEN INC","form":"8-K","filing_date":"2026-05-19","report_date":null,"primary_document":"amgn-20260519.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000097/amgn-20260519.htm"},"classifications":[{"id":21,"accession_number":"0000318154-26-000097","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses the appointment of Thomas Dittrich as Executive Vice President and Chief Financial Officer effective September 1, 2026, along with detailed compensation arrangements including base salary (CHF 1,070,000), equity grants (CHF 4,500,000 target), sign-on RSU award (CHF 4,700,000), and retention bonus (CHF 5,800,000). While the section also mentions Peter Griffith's retirement, the substantive focus and length of disclosure centers on Dittrich's appointment and his comprehensive compensation package, making this primarily an exec_appointment event. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:12:33.007181+00:00","company_name":"AMGEN INC","ticker":null,"filing_date":"2026-05-19"}]}